|
Volumn 30, Issue 7, 2002, Pages 411-416
|
Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a Veterans Affairs medical center
a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPICILLIN;
ANTIINFECTIVE AGENT;
AZTREONAM;
CEFAZOLIN;
CEFOPERAZONE;
CEFOTAXIME;
CEFOTETAN;
CEFTAZIDIME;
CEFTRIAXONE;
CEFUROXIME;
CEPHALOSPORIN DERIVATIVE;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
GENTAMICIN;
LEVOFLOXACIN;
MEROPENEM;
MEZLOCILLIN;
MONOBACTAM DERIVATIVE;
OFLOXACIN;
PIPERACILLIN;
SULTAMICILLIN;
TICARCILLIN;
TIMENTIN;
TOBRAMYCIN;
TROVAFLOXACIN;
ADULT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTERIAL INFECTION;
DATA ANALYSIS;
DRUG EFFECT;
FEMALE;
GENETIC SUSCEPTIBILITY;
GRAM NEGATIVE BACTERIUM;
HUMAN;
INTENSIVE CARE UNIT;
MAJOR CLINICAL STUDY;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
PSEUDOMONAS AERUGINOSA;
RISK ASSESSMENT;
WOUND INFECTION;
|
EID: 0036845391
PISSN: 01966553
EISSN: None
Source Type: Journal
DOI: 10.1067/mic.2002.124937 Document Type: Article |
Times cited : (30)
|
References (7)
|